President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Global pharmaceutical manufacturing industry market will reach $25.77 billion by 2032, growing by 9.3% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs ... illustrating ...

Korean biopharmaceutical firms have found temporary relief after being spared the “reciprocal” tariffs U.S. President Donald ...